세계의 의약품 조사 리뷰(2023년)

The global market for drugs of abuse (DOA) testing is estimated to increase from $5.2 billion in 2022 to reach $8.1 billion by 2027, at a compound annual growth rate (CAGR) of 9.3% from 2022 through 2027.

The global market for bioengineered protein drugs is estimated to increase from $354.1 billion in 2022 to reach $521.3 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.

The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.

Research Review Scope

The pharmaceutical market is one of the biggest industries in the world, and it is continuously growing. Continuous and ongoing research and development are happening in the pharmaceutical market, with the entry of new drugs and the performance of the current drugs. However, a drug's entry into the market takes around 12-13 years, but the market for existing drugs keeps soaring, which is why the pharmaceutical market keeps growing.

Research and development play a vital role in the growth of the pharmaceutical market, driven by technological and scientific advancements, especially in cell and gene therapies. The market is affected by stringent regulatory and reimbursement policies and escalating research and development costs. Artificial intelligence can be considered crucial with its usage in multiple fields of pharmaceuticals, such as drug discovery, clinical trials, drug screening, personalized medicine, supply chain management, regulatory compliance, pharmacovigilance, and marketing insights. Generative AI tools help accelerate drug discovery by automating tedious and time-consuming tasks.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2023 Pharmaceuticals Research Review provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2023:

PHM281A Anti Obesity Drugs Market

• PHM013J Drugs of Abuse Testing: Technologies and Global Markets
• BIO009H Global Markets for Bioengineered Protein Drugs
• HLC026G The Global Market for Pain Management Drugs and Devices

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Global Market for Anti-obesity Drugs (PHM281A)

• Anti-obesity Drugs
• Study Goals and Objectives
• Reasons for Doing this Study
• Scope of Report
• Market Outlook
• Market Summary
• Market Overview of Anti-obesity Drugs
• Definitions of Adult Obesity and Overweight
• Rising Prevalence of Obesity
• Impact of Obesity on Global Economy
• Increasing Awareness Regarding Obesity
• Global Market for Anti-obesity Drugs, by Type
• Prescription Drugs
• Over-the-Counter Anti-obesity Drugs
• Global Market for Anti-obesity Drugs, by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Global Market for Anti-obesity Drugs, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• ESG Developments of Anti-obesity Drugs
• Importance of ESG in Anti-obesity Drugs Industry
• ESG Pillars in the Anti-obesity Drug Industry
• ESG Ratings and Metrics: Understanding the Data
• ESG Practices in the Anti-obesity Drug Industry
• Concluding Remarks from BCC

Chapter 3 Drugs of Abuse Testing: Technologies and Global Markets (PHM013J)

• Drugs of Abuse Testing
• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Summary and Highlights
• Market and Technology Background of Drugs of Abuse Testing
• Overview
• Testing Technologies
• Single Tests vs. Multiparameter Tests
• DOA Screening
• Porter's Five Forces Analysis of Drugs of Abuse Testing
• Market Dynamics of Drugs of Abuse Testing
• Market Drivers
• Market Restraints
• Market Opportunities
• Regulatory Scenario of Drugs of Abuse Testing
• North America
• South America
• Central America and the Caribbean
• Europe
• Asia-Pacific
• Global Drugs of Abuse Testing Market, by Drug Type
• Alcohol
• Amphetamine and Methamphetamine
• Cannabis/Marijuana
• Cocaine
• Opioids
• Others
• Global Drugs of Abuse Testing Market, by End User
• Drug Testing Laboratories
• Hospitals
• Workplaces
• Others
• Market Breakdown of Drugs of Abuse Testing, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 4 Global Markets for Bioengineered Protein Drugs (BIO009H)

• Bioengineered Protein Drugs
• Study Goals and Objectives
• Scope of This Report
• Market Summary
• Market and Technology Background of Bioengineered Protein Drugs
• Protein Drugs Overview
• Bioengineered Protein Drugs
• Manufacturing Technologies of Bioengineered Protein Drugs
• Fractionation/Extraction from Natural Sources (Human/Animal)
• Microbial Fermentation and Bioreactors
• Transgenics
• Mammalian Cell Culture
• Market Dynamics of Bioengineered Protein Drugs
• Market Driver
• Market Challenges
• Market Breakdown of Bioengineered Protein Drugs by Drug Type
• Overview
• Monoclonal Antibodies (mAbs)
• Peptide Hormones
• Vaccines
• Fusion Proteins
• Blood Factors
• Peptide Antibiotics
• Cytokines
• Therapeutic Enzymes
• Market Breakdown of Bioengineered Protein Drugs, by Disease
• Overview
• Market Breakdown of Bioengineered Protein Drugs, by Region
• North America Market Revenue, by Drug Type
• Europe Market Revenue, by Drug Type
• Emerging Markets Revenue, by Drug Type
• Regulatory Aspects and New Approvals of Bioengineered Protein Drugs Market
• New Approvals
• Emerging Trends/Upcoming Technologies in the Market
• Bi- and Multi-Specific Antibodies
• Key Trends in Biopharmaceutical Industry

Chapter 5 Global Market for Pain Management Drugs and Devices (HLC026G)

• Pain Management Drugs and Device
• Study Goals and Objectives
• Reasons for Doing this Study
• Scope of Report
• Market Outlook
• Market Summary
• Highlights of the Market for Pain Management Drugs and Devices
• Market Overview of Pain Management Drugs and Device
• History of Pain and Pain Treatment
• The Perception of Pain
• Types of Pain
• Assessment of Pain
• How Pain is Diagnosed
• How Pain is Treated
• Market Dynamics of Pain Management Drugs and Device
• Market Drivers
• Market Restraints
• Market Challenges
• Market Breakdown of Pain Management Drugs and Device, by Product
• Pharmaceuticals
• Pain Management Devices
• Market Breakdown of Pain Management Drugs and Device, by Application
• Musculoskeletal Pain
• Post-operative Pain
• Neuropathic Pain
• Cancer Pain
• Migraine/Headache
• Other Applications
• Market Breakdown of Pain Management Drugs and Device, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• ESG Development of Pain Management Drugs and Device
• Introduction to ESG
• Sustainability in the Pain Management Drugs and Devices Industry: An ESG Perspective
• Case Study
• Concluding Remarks from BCC
• Emerging Technologies of Pain Management Drugs and Device
• Overview
• Technology Advancements in Opioid Drugs
• Technology Advancements in Non-narcotic Drugs
• Technology Advancements in Neuromodulation Devices
• Technology Advancements in Infusion Pumps
• Trends in Pain Management

Chapter 6 Appendix

• Methodology
• Analyst's Credentials